Review decisions
Showing 920 results of 2631 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00840
Product Type: Drug
Control Number: 247678
DIN(s): 02518244
Manufacturer: Amgen Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-12-18
Decision / Authorization Date: 2021-08-10
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00850
Product Type: Drug
Control Number: 249112
Manufacturer: Kyowa Kirin, Inc.
Submission Type: Supplement to a New Drug Submission - Priority Review
Date Filed / Submission Date: 2021-02-05
Decision / Authorization Date: 2021-08-10
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00964
Product Type: Drug
Control Number: 248367
Manufacturer: AstraZeneca Canada Inc.
Submission Type: Supplement to a New Drug Submission - Priority Review
Date Filed / Submission Date: 2021-01-15
Decision / Authorization Date: 2021-08-10
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00582
Product Type: Drug
Control Number: 254598
Manufacturer: Medicago Inc.
Submission Type: New Drug Submission (New Active Substance) (COVID-19)
Date Filed / Submission Date: 2021-08-09
Issued / Original Publication Date: 2022-04-11
Decision / Authorization Date: 2022-02-24
Updated Date: 2023-05-26
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00871
Product Type: Drug
Control Number: 231224
Manufacturer: Pacira Ltd.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2019-08-03
Decision / Authorization Date: 2021-08-05
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00847
Product Type: Drug
Control Number: 243456
Manufacturer: GlaxoSmithKline Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-09-01
Decision / Authorization Date: 2021-08-05
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00848
Product Type: Drug
Control Number: 243463
Manufacturer: GlaxoSmithKline Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-09-01
Decision / Authorization Date: 2021-08-05
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00842
Product Type: Drug
Control Number: 243699
Manufacturer: Amgen Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-09-04
Decision / Authorization Date: 2021-08-04
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00836
Product Type: Drug
Control Number: 251285
DIN(s): 02518341
Manufacturer: GlaxoSmithKline Canada Inc.
Submission Type: Application filed under section 3 of the Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19
Date Filed / Submission Date: 2021-04-01
Decision / Authorization Date: 2021-07-30
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00843
Product Type: Drug
Control Number: 243390
Manufacturer: GlaxoSmithKline Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-08-31
Decision / Authorization Date: 2021-07-29